PARP inhibitors are a class of drugs that target the enzyme poly (ADP-ribose) polymerase (PARP), which plays a crucial role in DNA repair. These drugs are used to treat certain types of cancer, particularly those with specific genetic mutations, by preventing cancer cells from repairing their damaged DNA, ultimately leading to cell death.